Market Place
Sourcing Support
Summit Shares Slip on Ivonescimab Interim Miss, Investors Wary
01 May 2026 //
ENDPOINTS
J&J Alleges Trade Secret Theft By Former Staffer Linked To Summit
16 Mar 2026 //
FIERCE PHARMA
Summit Therapeutics Releases Q4 2025 Financial Results
23 Feb 2026 //
BUSINESSWIRE
Summit Therapeutics Hosts Q4 & FY25 Earnings Call Feb. 23
17 Feb 2026 //
BUSINESSWIRE
Summit Therapeutics` Inducement Grants Under Nasdaq Listing Rule
30 Jan 2026 //
BUSINESSWIRE
Summit Therapeutics Reports Inducement Grants Under Nasdaq Rules
09 Jan 2026 //
BUSINESSWIRE
Summit Pharma To Present At J.P. Morgan Healthcare Conference
06 Jan 2026 //
BUSINESSWIRE
Summit Therapeutics Reports Inducement Grants Under Nasdaq Rules
05 Dec 2025 //
BUSINESSWIRE
Summit Pharma Hosts ESMO Data Update & Q3 Earnings Call On Oct
15 Oct 2025 //
BUSINESSWIRE
Summit Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
24 Sep 2025 //
BUSINESSWIRE
Summit Therapeutics to Host Update Call at WCLC 2025 on Sept 8
03 Sep 2025 //
BUSINESSWIRE
Summit Skips Investor Call Amid Deal Rumors
12 Aug 2025 //
FIERCE PHARMA
Summit Therapeutics` Q2 Financial Results & Operational Progress
11 Aug 2025 //
BUSINESSWIRE
Summit, Astrazeneca in Talks Over 15 B Cancer Drug Licensing Deal
05 Jul 2025 //
REUTERS
Revolution Medicine, Summit to Test RAS Inhibitor Combo in Cancer
30 Jun 2025 //
GLOBENEWSWIRE
Summit Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
06 Jun 2025 //
BUSINESSWIRE
Summit Therapeutics at 46th Annual Goldman Sachs Conference
05 Jun 2025 //
BUSINESSWIRE
Summit Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
16 May 2025 //
BUSINESSWIRE
Summit Therapeutics Reports Q1 Financial Results and Progress
01 May 2025 //
BUSINESSWIRE
Summit Therapeutics to Host Q1 2025 Results Call on May 1, 2025
24 Apr 2025 //
BUSINESSWIRE
Summit Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
04 Apr 2025 //
BUSINESSWIRE
Summit Therapeutics Reports Inducement Grants Under Nasdaq 5635(c)(4)
21 Mar 2025 //
BUSINESSWIRE
Robert LaCaze Joins Summit As Chief Commercial Officer
17 Mar 2025 //
BUSINESSWIRE
Summit Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
14 Mar 2025 //
BUSINESSWIRE
Summit Reports Q4, Full-Year 2024 Results & Operational Progress
24 Feb 2025 //
BUSINESSWIRE
Pfizer to explore ADCs combo with Summit`s PD-1/VEGF bispecific
24 Feb 2025 //
BUSINESSWIRE
Summit Therapeutics to Host Q4 & Full Year 2024 Financial Results
18 Feb 2025 //
BUSINESSWIRE
Summit Therapeutics Reports Inducement Grants Under Nasdaq LR
14 Feb 2025 //
BUSINESSWIRE
Summit Therapeutic Report Inducement Grants Under Nasdaq 5635(c)(4)
16 Jan 2025 //
BUSINESSWIRE
Summit Therapeutics To Present At 43rd Annual JP Morgan Conference
07 Jan 2025 //
BUSINESSWIRE
Summit Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
13 Dec 2024 //
BUSINESSWIRE
Summit Therapeutics to Present at Upcoming Investor Conferences
26 Nov 2024 //
BUSINESSWIRE
Summit Therapeutics Reports Inducement Grants Under Nasdaq Rule
21 Nov 2024 //
BUSINESSWIRE
Summit Therapeutics Reports Q3 2024 Progress & Financial Results
30 Oct 2024 //
BUSINESSWIRE
Summit Therapeutics Q3 2024 Results & Operational Progress Call
23 Oct 2024 //
BUSINESSWIRE
Summit Therapeutics Reports Inducement Grants Under Nasdaq Rule
04 Oct 2024 //
BUSINESSWIRE
PESG Reports On Nuvectis Pharma`s NXP900
16 Sep 2024 //
BUSINESSWIRE
Summit Therapeutics Reports Inducement Grants Under Nasdaq Rule
06 Sep 2024 //
BUSINESSWIRE
Two Ivonescimab Results For NSCLC To Be Presented At WCLC 2024
12 Aug 2024 //
PR NEWSWIRE
Summit Therapeutics Reports Inducement Grants
09 Aug 2024 //
BUSINESSWIRE
Summit Therapeutics Reports Q2 2024 Financial Results And Progress
06 Aug 2024 //
BUSINESSWIRE
Summit Therapeutics To Host Q2 2024 Results Call On August 6
29 Jul 2024 //
BUSINESSWIRE
Summit And MD Anderson Partner On Ivonescimab Development
25 Jul 2024 //
BUSINESSWIRE
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635
03 Jul 2024 //
BUSINESSWIRE
Summit Appoints Jeff Huber, Transformational Google and GRAIL Executive
27 Jun 2024 //
BUSINESSWIRE
Summit Reports Inducement Grants Per Nasdaq Rule
30 May 2024 //
BUSINESSWIRE
Summit Therapeutics Q1 2024 Financial Results, Operational Progress
01 May 2024 //
BUSINESSWIRE
Summit Hosts Q1 2024 Call on May 1
24 Apr 2024 //
BUSINESSWIRE
Summit Appoints Dr. Ronaghi To Board
11 Apr 2024 //
BUSINESSWIRE
Summit Therapeutics to Present at the Stifel 2024 Targeted Oncology Forum
10 Apr 2024 //
BUSINESSWIRE
Illumina CFO Goswami to depart, former Summit exec Dhingra to succeed
09 Apr 2024 //
REUTERS
Summit to Present at the Barclays 26th Annual Global Healthcare Conference
05 Mar 2024 //
BUSINESSWIRE
Summit Therapeutics Reports Financial Results for the Fourth Quarter
20 Feb 2024 //
BUSINESSWIRE
Summit Therapeutics to Host Fourth Quarter & Full Year 2023 Financial Results
14 Feb 2024 //
BUSINESSWIRE
Summit to Present at Oppenheimer’s 34th Annual Life Sciences Conference
07 Feb 2024 //
BUSINESSWIRE
Summit Therapeutics Announces Updated Phase II Data for Ivonescimab
08 Jan 2024 //
BUSINESSWIRE
Summit to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 //
BUSINESSWIRE
Summit Therapeutics Reports Financial Results for the Third Quarter
07 Nov 2023 //
BUSINESSWIRE
Summit Therapeutics to Host Q3 2023 Financial Results
26 Oct 2023 //
BUSINESSWIRE
Summit Reports Financial Results for Q2 and Six Months Ended June 30, 2023
09 Aug 2023 //
BUSINESSWIRE
